ALLMedicine™ Prostate Cancer Center
Research & Reviews 40,135 results
The Oncologist; Meza L, Zengin Z et. al.
Mar 28th, 2023 - Vaccinations against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have had a transformative impact on morbidity and mortality. However, the long-term impact of vaccination on patients with genitourinary cancers is currently unknown...
Journal of Basic and Clinical Physiology and Pharmacology; La Civita E, Carbone G et. al.
Mar 28th, 2023 - Investigating periprostatic adipose tissue as a driving force of prostate cancer progression: a new source of information for the advancement of targeted therapy in metastatic prostate cancer.|2023|La Civita E,Carbone G,Sicignano E,Crocetto F,Terr...
Current Opinion in Oncology; Gourdin T, Velayati A
Mar 27th, 2023 - This review is designed to highlight recent research examining treatment progress in advanced prostate cancer while identifying ongoing challenges to clinical outcomes. Recent randomized trials suggest an overall survival advantage to treating som...
Current Opinion in Oncology; Rednam N, Kundra V
Mar 27th, 2023 - Recurrence post definitive local therapy by prostatectomy or radiation therapy is often detected via rise in serum prostate-specific antigen (PSA) levels; however, PSA rise does not localize the disease. Distinguishing local versus distant recurre...
Current Opinion in Oncology; Patel L, Pritchard CC
Mar 27th, 2023 - Personalizing prostate cancer therapy requires germline and tumor molecular tests that predict who will respond to specific treatments and who may not. The review covers molecular testing of DNA damage response pathways, the first biomarker-driven...
Guidelines 84 results
Annals of Oncology : Official Journal of the European Soc... Fizazi K, Gillessen S et. al.
Mar 24th, 2023 - Updated treatment recommendations for prostate cancer from the ESMO Clinical Practice Guideline considering treatment intensification and use of novel systemic agents.|2023|Fizazi K,Gillessen S, ,|
European Urology Focus; Nguyen DD, Wallis CJD et. al.
Feb 27th, 2023 - Cancer survivorship is particularly significant for patients with urologic malignancies, who account for >25% of cancer survivors. The American Cancer Society has a guideline on survivorship care in prostate cancer and the American Urological Asso...
European Urology Focus; Pratsinis M, Dall'Era M
Aug 29th, 2022 - Prostate cancer is the most common solid cancer among men. Multiple blood-, urine-, and tissue-based biomarkers are currently commercially available and can improve the detection and risk stratification of prostate cancer. These biomarkers are sti...
Loma Linda University Health; Aubry L.
Jun 8th, 2022 - Men with higher intakes of dairy foods, especially milk, face a significantly higher risk of prostate cancer compared to men with lower intakes, according to a new study conducted by researchers at Loma Linda University Health. The study found no ...
American Journal of Clinical Oncology; Bittner NHJ, Cox BW et. al.
May 20th, 2022 - The American College of Radiology (ACR), American Brachytherapy Society (ABS), and American Society for Radiation Oncology (ASTRO) have jointly developed the following practice parameter for transperineal permanent brachytherapy of prostate cancer...
Drugs 264 results see all →
Clinicaltrials.gov 5,113 results
Mar 24th, 2023 - PRIMARY OBJECTIVES: I. To compare radiographic progression-free survival (rPFS) and overall survival (OS) with enzalutamide and rucaparib camsylate (rucaparib) versus enzalutamide alone for patients with metastatic castration resistant prostate ca...
Mar 24th, 2023 - Participants with mCRPC previously treated with docetaxel-based chemotherapy in Cohorts 1 to 3 will receive monotherapy with pembrolizumab. Chemotherapy-naïve subjects with mCRPC either having failed or showing signs of failure with enzalutamide i...
Mar 24th, 2023 - This study offers focal stereotactic body radiotherapy for prostate cancer by using an intra-urethral radiotransponder placed temporarily during each of the 5 radiotherapy treatments. The study aims to improve the risk-benefit ratio of therapy for...
Mar 24th, 2023 - PRIMARY OBJECTIVE: I. To investigate the association between hyperpolarized (HP) pyruvate-to-lactate conversion (kPL) and HP urea perfusion with histologic grade of prostate cancer, including benign prostate tissue, low grade disease (primary Glea...
Mar 24th, 2023 - The purpose of this study is to assess the safety and effectiveness of nivolumab with docetaxel in men with advanced castration resistant prostate cancer who have progressed after second-generation hormonal manipulation.
News 7,866 results
Amanda J. Compadre, MD, David G. Mutch, MD et. al.
Mar 26th, 2023 - CASE Patient inquires about new technology to detect cancer A 51-year-old woman (para 2) presents to your clinic for a routine gynecology exam. She is up to date on her screening mammogram and Pap testing.
Mar 23rd, 2023 - The residents of an area of Louisiana running along the Mississippi River between New Orleans and Baton Rouge, known as "Cancer Alley," have filed a federal lawsuit against their local government, alleging that petrochemical plants built in the ar...
Mar 23rd, 2023 - Key clinical point: Compared with mild atopic dermatitis (AD), severe AD results in an increased risk for overall morbidity. Major finding: Patients with severe vs mild AD had a significantly increased risk for other dermatitis, extragenital herpe.
Mar 17th, 2023 - Note that some links may require subscriptions. A new analysis of genetic samples from China appears to link the origin of COVID-19 to raccoon dogs. (The Atlantic) What's a raccoon dog, anyhow? (Wikipedia) After a 2-year pandemic spike, maternal d...
Mar 16th, 2023 - Lutetium Lu 177 vipivotide tetraxetan (Pluvicto) is currently in shortage, according to the FDA, leaving some prostate cancer patients with limited options; the drug's manufacturer Novartis said it's working to increase production. Meanwhile, the ...